Prep: Delivery bottlenecks for HIV prevention drugs

Prep: Delivery bottlenecks for HIV prevention drugs


In Germany, a drug used by tens of thousands of people to protect against HIV infection is currently not sufficiently available. Several manufacturers of so-called pre-exposure prophylaxis, or Prep for short, have reported supply bottlenecks, as the Federal Institute for Drugs and Medical Devices (BfArM) announced. Since the turn of the year there has been a “development towards limited availability” of the drug approved in Germany.

Since September 2019, the drug has been included in statutory health insurance benefits for people with an increased risk of HIV infection. The tablets suppress the virus from multiplying in the body.

“Politicians must not abandon people who urgently need this medication,” said Sven Warminsky from the board of the German Aid Aid Association a few weeks ago. If the protection before HIV If it continues to fail, it will have “fatal consequences”.

This article will continue to be updated.



Source link